Albuterol Plus Budesonide Reduces Exacerbations in Asthma
As-needed use of a fixed combination of albuterol and budesonide is associated with a lower risk for severe asthma exacerbations.
As-needed use of a fixed combination of albuterol and budesonide is associated with a lower risk for severe asthma exacerbations.
Patients diagnosed with cancer more than one year ago and those not receiving active treatment are not at heightened risk for worse COVID-19.
Rare cases of COVID-19 patients relapsing after taking the antiviral pill Paxlovid are raising questions among some experts.
A study examining hemodynamically guided management of patients with chronic HF found significant changes in clinical outcomes during the COVID-19 pandemic.
In this retrospective cohort study, researchers assessed the rate of treatment failure among patients with COVID-19 infection who received bamlanivimab vs those who received casirivimab/imdevimab.
The U.S. FDA approved the first generic of Symbicort Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in patients with COPD.
COVID-19 convalescent plasma administered to mostly unvaccinated outpatients within nine days after symptom onset reduced the risk of progression of COVID-19 leading to hospitalization.
Researchers evaluated the safety, effectiveness, and cardiotoxity risk associated with concomitant treatment with bedaquiline and delamanid in patients with multidrug-resistant tuberculosis infection.
The American College of Physicians provides an overview of the final update to the rapid, living practice points on the use of remdesivir for the treatment of COVID-19 infection.
Investigators at the Centers for Disease Control and Prevention evaluated the effect of a novel 4-month regimen for the treatment of drug-susceptible tuberculosis infection.